| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.31T | 15.97T | 16.00T | 17.80T | 19.66T | 14.47T |
| Gross Profit | 5.76T | 4.76T | 3.28T | 4.56T | 5.07T | 2.92T |
| EBITDA | 5.90T | 5.00T | 3.64T | 4.26T | 4.32T | 3.02T |
| Net Income | 1.16T | 1.12T | 614.24B | 769.98B | 759.13B | 19.91B |
Balance Sheet | ||||||
| Total Assets | 40.62T | 39.13T | 37.12T | 38.27T | 37.65T | 37.49T |
| Cash, Cash Equivalents and Short-Term Investments | 7.32T | 5.95T | 5.23T | 4.42T | 3.76T | 2.45T |
| Total Debt | 8.41T | 7.87T | 7.93T | 9.31T | 10.38T | 11.42T |
| Total Liabilities | 14.26T | 13.27T | 13.20T | 15.11T | 16.28T | 17.04T |
| Stockholders Equity | 14.63T | 14.30T | 13.54T | 12.90T | 11.56T | 11.31T |
Cash Flow | ||||||
| Free Cash Flow | 1.66T | 667.13B | 2.54T | 2.14T | 2.43T | 1.11T |
| Operating Cash Flow | 3.22T | 2.23T | 3.80T | 3.59T | 3.72T | 2.54T |
| Investing Cash Flow | -1.80T | -1.44T | -1.25T | -1.43T | -1.33T | -1.58T |
| Financing Cash Flow | 322.66B | -147.66B | -1.72T | -1.63T | -1.09T | -314.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €2.46B | 11.08 | 20.72% | 6.48% | 15.89% | 21.52% | |
74 Outperform | S$502.53M | 5.22 | 8.46% | 2.70% | 13.03% | 35.10% | |
70 Outperform | S$77.49M | 2.76 | 54.02% | ― | 41.78% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $3.55B | 6.35 | 8.32% | 2.92% | 16.86% | 252.80% | |
62 Neutral | €450.20M | 5.87 | 7.17% | 0.60% | 47.72% | 16.14% |